Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments
Metadatos
Afficher la notice complèteAuteur
Galue Parra, Adán Jesús; Jiménez-Falcao, Sandra; Arribas Yuste, Esther; Marín Sánchez, Clotilde; Méndez Arriaga, José ManuelEditorial
MDPI
Materia
parasite Leishmania neglected diseases sialic acid Colchicine Drug delivery Nanoparticle
Date
2025-07-06Referencia bibliográfica
Galue-Parra, A.J.; Jimenez-Falcao, S.; Arribas-Yuste, E.; Marin, C.; Mendez-Arriaga, J.M. Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments. Biomedicines 2025, 13, 1648. https://doi.org/10.3390/ biomedicines13071648
Patrocinador
Brasil (CAPES)—Programa de Doutorado Sanduíche no Exterior (PDSE) (Code 88881.846500/2023-01); Agencia Estatal de Investigación, España (Code PID2022-136417NB-I00)Résumé
Background/Objectives: Leishmaniasis remains a neglected tropical disease, with nearly
one million new cases annually and limited investment in research. Current treatments,
primarily based on pentavalent antimonials, are associated with severe side effects and
increasing resistance. This study aims to develop a novel therapeutic strategy using a
nanomaterial functionalized with sialic acid (SA) and colchicine (COL) to selectively target
Leishmania braziliensis parasites. Methods: A nanostructured system was engineered by
functionalizing its surface with SA and COL. SA was chosen to mimic host cell surfaces, enhancing parasite attraction, while COL was selected for its known leishmanicidal properties.
The nanomaterial was designed to concentrate extracellular parasites on its surface via SAmediated interactions, thereby increasing local COL efficacy. Results: The functionalized
nanomaterial demonstrated a dual mechanism: SA facilitated the selective accumulation of
Leishmania braziliensis parasites on the nanostructure surface, while COL exerted a cytotoxic
effect. This synergistic interaction resulted in enhanced parasite mortality in vitro, suggesting improved selectivity and potency compared to conventional treatments. Conclusions:
The proposed nanomaterial offers a promising alternative for leishmaniasis treatment by
combining targeted parasite attraction with localized drug delivery. This strategy may
reduce systemic toxicity and improve therapeutic outcomes.